Rimactazid 150 mg / 75 mg Noruega - noruego - Statens legemiddelverk

rimactazid 150 mg / 75 mg

sandoz - københavn - rifampicin / isoniazid - tablett, filmdrasjert - 150 mg / 75 mg

Talzenna Unión Europea - noruego - EMA (European Medicines Agency)

talzenna

pfizer europe ma eeig - talazoparib - bryst neoplasms - antineoplastiske midler - talzenna er indisert som monoterapi for behandling av voksne pasienter med germline brca1/2 mutasjoner, som har her2-negative lokalt avansert eller metastatisk brystkreft. patients should have been previously treated with an anthracycline and/or a taxane in the (neo)adjuvant, locally advanced or metastatic setting unless patients were not suitable for these treatments. pasienter med hormon-reseptor (hr)-positiv brystkreft burde ha blitt behandlet med en tidligere endokrine-basert terapi, eller anses som uegnet for endokrin-basert terapi.

Xospata Unión Europea - noruego - EMA (European Medicines Agency)

xospata

astellas pharma europe b.v. - gilteritinib fumarate - leukemi, myeloid, akutt - antineoplastiske midler - xospata er indisert som monoterapi for behandling av voksne pasienter som har tilbakefall eller ildfast akutt myelogen leukemi (aml) med en mutasjon flt3.

Fampridine Accord Unión Europea - noruego - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Jyseleca Unión Europea - noruego - EMA (European Medicines Agency)

jyseleca

gilead sciences ireland uc, galapagos nv - filgotinib maleate - leddgikt, reumatoid - immunsuppressive - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Orgovyx Unión Europea - noruego - EMA (European Medicines Agency)

orgovyx

accord healthcare s.l.u. - relugolix - prostata neoplasmer - endokrin terapi - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

Fampridine Sandoz 10 mg Noruega - noruego - Statens legemiddelverk

fampridine sandoz 10 mg

sandoz a/s - fampridin - depottablett - 10 mg

Rimactan 150 mg Noruega - noruego - Statens legemiddelverk

rimactan 150 mg

sandoz gmbh - rifampicin - kapsel, hard - 150 mg

Rimactan 300 mg Noruega - noruego - Statens legemiddelverk

rimactan 300 mg

sandoz gmbh - rifampicin - kapsel, hard - 300 mg

Rimactan 300 mg Noruega - noruego - Statens legemiddelverk

rimactan 300 mg

2care4 aps - rifampicin - kapsel, hard - 300 mg